Half of Patients With Post-BCG Bladder Cancer Achieve CR With Nonviral Gene Therapy

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

Half of Patients With Post-BCG Bladder Cancer Achieve CR With Nonviral Gene Therapy (MedPage Today) — WASHINGTON — More than half of previously treated non-muscle-invasive bladder cancer (NMIBC) patients had complete responses (CR) with intravesical gene therapy, according to preliminary results from an ongoing study…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button